Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-588
Closed -$116K 212
2024
Q4
$116K Sell
588
-130,073
-100% -$27.4M ﹤0.01% 189
2024
Q3
$31M Sell
130,661
-3,175
-2% -$749K 0.97% 49
2024
Q2
$28.3M Buy
+133,836
New +$30.4M 0.94% 48
2020
Q1
Sell
-2,952
Closed -$453K 359
2019
Q4
$453K Sell
2,952
-7,954
-73% -$1.16M 0.05% 286
2019
Q3
$1.61M Buy
10,906
+5,091
+88% +$792K 0.08% 257
2019
Q2
$912K Hold
5,815
0.07% 276
2019
Q1
$824K Sell
5,815
-4,288
-42% -$572K 0.07% 283
2018
Q4
$1.14M Sell
10,103
-20,154
-67% -$2.44M 0.14% 200
2018
Q3
$3.94M Buy
30,257
+17,882
+145% +$2.15M 0.23% 130
2018
Q2
$1.24M Sell
12,375
-13,706
-53% -$1.37M 0.08% 242
2018
Q1
$2.56M Sell
26,081
-5,990
-19% -$605K 0.1% 244
2017
Q4
$3.17M Buy
+32,071
New +$3.26M 0.12% 211
2017
Q2
Sell
-7,366
Closed -$587K 317
2017
Q1
$587K Buy
+7,366
New +$575K 0.02% 301

Other funds holding IQV

Meag Munich Ergo's IQV Position: Q1 2025 in Review

Meag Munich Ergo sold out of IQVIA (IQV) in Q1 2025, closing a stake of 588 shares — an estimated $116K sold.

Meag Munich Ergo first reported a position in IQV in Q1 2017 and held it in 13 quarters. The position peaked at $31M in Q3 2024. 989 funds tracked by Wall St. Rank hold IQV as of Q1 2025.

  • Meag Munich Ergo reported no remaining IQVIA position as of Q1 2025 after selling out during the quarter.
  • Meag Munich Ergo sold 588 IQVIA shares in Q1 2025, an estimated $116K.
  • Meag Munich Ergo first reported a position in IQVIA in Q1 2017 and held it in 13 quarters.
  • Meag Munich Ergo's IQVIA position peaked at $31M in Q3 2024.
  • 989 funds tracked by Wall St. Rank held IQVIA as of Q1 2025.

Based on Meag Munich Ergo's 13F filing for Q1 2025, filed 17 Apr 2025.